GE HealthCare has secured CE Mark certification for its MINItrace Magni cyclotron and expanded the PETtrace Solid Target Platform to Copper-64.

This collaborative research applies generative artificial intelligence to synthesize clinical data, enabling personalized oncology workflows and accelerating patient progression from diagnosis to treatment.

GE HealthCare introduced a cloud application to forecast hospital capacity constraints, deploying machine learning models across health system networks.

GE HealthCare has submitted the StarGuide GX 4D CZT SPECT/CT system for U.S. FDA 510(k) clearance, aiming to expand advanced molecular imaging and theranostics capabilities following its recent European CE Mark.

GE HealthCare introduced three cardiovascular ultrasound systems engineered to standardize beamforming architecture and automated diagnostic quantification across varied clinical healthcare settings.

GE HealthCare expands its portable ultrasound platform with two laptop-sized systems combining AI-assisted acquisition, workflow automation and multi-specialty imaging capabilities.

Invenia ABUS Prime and ABUS StreamVue enhance supplemental breast screening with standardized imaging, remote review and enterprise-wide workflow integration.

The vendor-neutral MIM Anyware web application provides secure remote access to medical imaging data, enhancing real-time multidisciplinary collaboration and streamlining clinical decision-making.

GE HealthCare and Mayo Clinic are collaborating to evaluate imaging-guided radioligand therapy for patients with advanced prostate cancer.

New upgrade options provide access to AI-enabled Allia technologies while extending system lifecycles and preserving existing infrastructure investments.